Biopharmaceuticals Contract Manufacturing Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Biopharmaceuticals Contract Manufacturing Market

Description:

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion by 2025 – PowerPoint PPT presentation

Number of Views:1

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Biopharmaceuticals Contract Manufacturing Market


1
Biopharmaceuticals Contract Manufacturing Market
Size, Share Trends Analysis Report and Segment
Forecast, 2025 Grand View Research, Inc
The global biopharmaceuticals contract
manufacturing market size was valued at USD
12.14 billion in 2017 and is projected to exhibit
a CAGR of 7.5 during the forecast period.
The global Biopharmaceuticals Contract
Manufacturing Market size is expected to reach
USD 21.7 billion by 2025, according to a new
report by Grand View Research, Inc., registering
a CAGR of 7.5 during the forecast period.
Growing biopharmaceutical pipeline and lack of
adequate manufacturing capabilities are two key
factors driving partnerships between large
molecule manufacturers and contract manufacturing
organizations (CMOs). Contract manufacturers are
engaged in broadening their service portfolio to
meet companies demand with respect to
regulatory standards and new services. Reliance
of companies on CMOs for production of biologics
and biosimilars is expected to rise over the
forecast period as a consequence of changes
adopted by CMOs. This is evident through growing
investments in collaborations of companies with
CMOs as well as continuous efforts taken up for
broadening service portfolios. The growth of
CMOs is highly dependent on promising
opportunities offered by the biopharmaceutical
industry, bioprocessing industry, and contract
service industry. Expansion of fill-and-finish
services and increasing robustness of venture
capital investments in the life science sector
are important opportunities that are anticipated
to drive the market. To request a sample copy or
view summary of this report, click the link
below https//www.grandviewresearch.com/industry-
analysis/biopharmaceuticals-contract-manufacturing
-market
2
  • Further key findings from the report suggest
  • Based on source, mammalian-based
    biopharmaceutical contract manufacturing captured
    the largest market share owing to high
    penetration of mammalian expression systems for
    biologics development
  • By service, upstream and downstream services
    accounted for the largest revenue share.
    Complexities associated with these steps
    pronounces demand for established contract
    manufacturers to ensure manufacturing processes
    compliant with regulatory standards
  • Biologics contract manufacturing dominated the
    market based on product owing to higher demand
    for biologics production. However, the
    biosimilar segment is slated to exhibit a
    lucrative CAGR due to cost- saving advantages
    associated with its development
  • Presence of effective regulatory framework for
    biologics development in U.S. has resulted in
    North America market accounting for the dominant
    share in 2017. However, Asia Pacific is expected
    to emerge as the fastest growing regional
    market, with developing economies expanding at a
    substantial pace and incorporating developments
    to sustain the competition
  • Several international companies are seeking
    outsourcing of biopharmaceutical production to
    Asian countries owing to continuous expansion of
    Asian CMOs that offer services at a reduced
    price, compared to service providers based in
    western countries
  • Some of the key service providers are Boehringer
    Ingelheim GmbH Lonza Samsung BioLogics and
    FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Grand View Research has segmented the global
    biopharmaceuticals contract manufacturing market
    on the basis of source, service, product, and
    region
  • Biopharmaceuticals Contract Manufacturing Source
    Outlook (Revenue, USD Million, 2014 - 2025)
  • Mammalian
  • Non-mammalian

3
  • Biopharmaceuticals Contract Manufacturing Product
    Outlook (Revenue, USD Million, 2014 - 2025)
  • Biologics
  • Monoclonal Antibodies (MAbs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, Molecular Therapy
  • Others
  • Biosimilars
  • Biopharmaceuticals Contract Manufacturing
    Regional Outlook (Revenue, USD Million, 2014 -
    2025)
  • North America

4
  • Table of Content of Biopharmaceuticals Contract
    Manufacturing Market
  • Chapter 1 Executive Summary
  • 1.1 Market Snapshot
  • Chapter 2 Research Methodology
  • Information Procurement
  • Purchased Database
  • GVRs Internal Database
  • Data Analysis
  • Market Formulation Validation
  • Approaches for Market Estimation
  • Approach 1 Commodity Flow Bottom Up Approach
  • Approach 2 Top Down and Parent Market Analysis
  • Chapter 3 Market Variables, Trends Scope
  • Market Segmentation Scope
  • Market driver analysis
  • Rise in investment by CMOs for capacity expansion
  • Commercial success of biopharmaceuticals and
    consequent increase in demand for
    biopharmaceuticals
  • 3.1.1.2.1 Notable growth of biologics

5
  • Pipeline Analysis
  • Distribution of products projects in
    development stage by clinical phase
  • Key finding of the analysis
  • Pipeline analysis for biosimilar drugs, as of
    February 2018
  • Total global biopharmaceutical RD spending
  • Number of drugs in clinical development phase,
    2015
  • Pricing Analysis for Process Development
  • Cell line/expression system pricing
  • Bioreactor cost
  • Operating and construction cost advantage due to
    single-use bioprocessing equipment
  • Bioprocessing operating cost items and ranges
  • Bioprocessing pricing analysis based on product
    type
  • Downstream bioprocessing pricing analysis
  • Cost analyses for buffer purchasing
  • Penetration Growth Prospect Mapping for Contract
    Manufacturing Service, 2017
  • Biopharmaceuticals Contract Manufacturing Market
    - Swot Analysis, By Factor (Political Legal,
    Economic And Technological)
  • Industry Analysis - Porters
  • Customer Relationship Management in Contract
    Manufacturing
  • Selection process of CMO

6
  • Downstream processing
  • Global downstream processing market, 2014 - 2025
    (USD Million)
  • Upstream processing
  • Global upstream processing market, 2014 - 2025
    (USD Million)
  • Fill finish operations
  • 5.3.1 Global fill finish operations market,
    2014 - 2025 (USD Million)
  • Analytical QC testing
  • Global analytical QC testing market, 2014 -
    2025 (USD Million)
  • Packaging
  • Global contract packaging market, 2014 - 2025
    (USD Million)
  • Chapter 6 Biopharmaceuticals Contract
    Manufacturing Market Product Estimates Trend
    Analysis
  • Global Biopharmaceuticals Contract Manufacturing
    Market Product Movement Analysis
  • Biologics
  • Global biologics market, 2014 - 2025 (USD
    Million)
  • Monoclonal Antibodies
  • Global monoclonal antibodies market, 2014 - 2025
    (USD Million)
  • Recombinant proteins
  • Global recombinant proteins market, 2014 - 2025
    (USD Million)
  • Vaccines

7
  • U.S.
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Bbiopharmaceuticals contract manufacturing
    market, by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • Canada
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • Europe
  • Biopharmaceuticals contract manufacturing market,
    2014 - 2025 (USD Million)
  • Germany
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • France
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • Asia Pacific

8
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • Middle East Africa (MEA)
  • Biopharmaceuticals contract manufacturing market,
    2014 - 2025 (USD Million)
  • South Africa
  • Biopharmaceuticals contract manufacturing market,
    by source, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by service, 2014 - 2025 (USD Million)
  • Biopharmaceuticals contract manufacturing market,
    by product, 2014 - 2025 (USD Million)
  • Chapter 8 Competitive Landscape
  • Strategy Framework
  • Market Participation Categorization
  • Company Profiles
  • Boehringer Ingelheim GmbH
  • Company overview
  • Financial performance
  • Product benchmarking
  • Strategic initiatives
  • Lonza

9
  • Product benchmarking
  • Strategic initiatives
  • JRS PHARMA
  • Company overview
  • CELONIC AG
  • Financial performance
  • Financial performance
  • Product benchmarking
  • Strategic initiatives
  • AGC Biologics
  • Company overview
  • BIOMEVA GmbH
  • Company overview
  • CMC Biologics
  • Company overview
  • Financial performance of AGC
  • Financial performance of BIOMEVA GmbH
  • Financial performance of CMC Biologics
  • Product benchmarking

10
  • 8.3.8.4 Strategic initiatives
  • TOYOBO CO., LTD.
  • Company overview
  • Financial performance
  • Product benchmarking
  • Strategic initiatives
  • Samsung BioLogics
  • Company overview
  • Financial performance
  • Product benchmarking
  • Strategic initiatives
  • Thermo Fisher Scientific, Inc.
  • Company Overview
  • Patheon
  • 8.3.11.2.1 Company overview 8.3.11.2.1.1 DPx
  • 8.3.11.2 Financial Performance of Thermo Fisher
    Scientific, Inc.
  • 8.3.11.2.1 Financial performance of Patheon
  • Product benchmarking
  • Strategic initiatives

11
  1. Financial performance
  2. Product benchmarking
  3. Strategic initiatives

About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA Grand View Research, Inc Phone
1-415- 349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/
About PowerShow.com